Psychiatric comorbidities in children and adolescents with psoriasis - a population-based cohort study

Publikation: Bidrag til tidsskrift › Letter › Forskning › fagfællebedømt

Standard

Psychiatric comorbidities in children and adolescents with psoriasis - a population-based cohort study. / Todberg, T; Egeberg, A; Jensen, P; Gislason, G; Skov, Lone.

I: British Journal of Dermatology, Bind 177, Nr. 2, 08.2017, s. 551-553.

Publikation: Bidrag til tidsskrift › Letter › Forskning › fagfællebedømt

Harvard

Todberg, T, Egeberg, A, Jensen, P, Gislason, G & Skov, L 2017, 'Psychiatric comorbidities in children and adolescents with psoriasis - a population-based cohort study', British Journal of Dermatology, bind 177, nr. 2, s. 551-553. https://doi.org/10.1111/bjd.15095

APA

Todberg, T., Egeberg, A., Jensen, P., Gislason, G., & Skov, L. (2017). Psychiatric comorbidities in children and adolescents with psoriasis - a population-based cohort study. British Journal of Dermatology, 177(2), 551-553. https://doi.org/10.1111/bjd.15095

Vancouver

Todberg T, Egeberg A, Jensen P, Gislason G, Skov L. Psychiatric comorbidities in children and adolescents with psoriasis - a population-based cohort study. British Journal of Dermatology. 2017 aug.;177(2):551-553. https://doi.org/10.1111/bjd.15095

Author

Todberg, T ; Egeberg, A ; Jensen, P ; Gislason, G ; Skov, Lone. / Psychiatric comorbidities in children and adolescents with psoriasis - a population-based cohort study. I: British Journal of Dermatology. 2017 ; Bind 177, Nr. 2. s. 551-553.

Bibtex

@article{bbe28cbdf2f4452183c21e870b5af2e7,
title = "Psychiatric comorbidities in children and adolescents with psoriasis - a population-based cohort study",
abstract = "Psoriasis is present in 2-3% of the adult European population(1) and 0.7-1.2% in children(1,2) . Adults with psoriasis have increased risk of depression(3) , and US data reported an increased risk of psychiatric diseases in pediatrics with psoriasis(4) , however European data are lacking. Primary outcomes were to examine the risk of psychiatric disorders including use of psychopharmacotherapy in children with psoriasis compared to healthy controls in a population-based cohort study. This article is protected by copyright. All rights reserved.",
keywords = "Letter",
author = "T Todberg and A Egeberg and P Jensen and G Gislason and Lone Skov",
note = "This article is protected by copyright. All rights reserved.",
year = "2017",
month = aug,
doi = "10.1111/bjd.15095",
language = "English",
volume = "177",
pages = "551--553",
journal = "British Journal of Dermatology",
issn = "0007-0963",
publisher = "Wiley-Blackwell",
number = "2",

}

RIS

TY - JOUR

T1 - Psychiatric comorbidities in children and adolescents with psoriasis - a population-based cohort study

AU - Todberg, T

AU - Egeberg, A

AU - Jensen, P

AU - Gislason, G

AU - Skov, Lone

N1 - This article is protected by copyright. All rights reserved.

PY - 2017/8

Y1 - 2017/8

N2 - Psoriasis is present in 2-3% of the adult European population(1) and 0.7-1.2% in children(1,2) . Adults with psoriasis have increased risk of depression(3) , and US data reported an increased risk of psychiatric diseases in pediatrics with psoriasis(4) , however European data are lacking. Primary outcomes were to examine the risk of psychiatric disorders including use of psychopharmacotherapy in children with psoriasis compared to healthy controls in a population-based cohort study. This article is protected by copyright. All rights reserved.

AB - Psoriasis is present in 2-3% of the adult European population(1) and 0.7-1.2% in children(1,2) . Adults with psoriasis have increased risk of depression(3) , and US data reported an increased risk of psychiatric diseases in pediatrics with psoriasis(4) , however European data are lacking. Primary outcomes were to examine the risk of psychiatric disorders including use of psychopharmacotherapy in children with psoriasis compared to healthy controls in a population-based cohort study. This article is protected by copyright. All rights reserved.

KW - Letter

U2 - 10.1111/bjd.15095

DO - 10.1111/bjd.15095

M3 - Letter

C2 - 27681652

VL - 177

SP - 551

EP - 553

JO - British Journal of Dermatology

JF - British Journal of Dermatology

SN - 0007-0963

IS - 2

ER -

ID: 174210577